End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
31.32 CNY | +3.16% | +2.02% | +2.63% |
Apr. 22 | CSPC Innovation Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 19 | China's drugmakers can't sell mRNA shots but haven't quit yet | RE |
Sales 2024 * | 3.06B 423M | Sales 2025 * | 4.09B 565M | Capitalization | 43.99B 6.08B |
---|---|---|---|---|---|
Net income 2024 * | 722M 99.71M | Net income 2025 * | 952M 131M | EV / Sales 2024 * | 13.8 x |
Net cash position 2024 * | 1.57B 217M | Net cash position 2025 * | 5B 690M | EV / Sales 2025 * | 9.53 x |
P/E ratio 2024 * |
61
x | P/E ratio 2025 * |
47.9
x | Employees | 1,887 |
Yield 2024 * |
0.85% | Yield 2025 * |
0.41% | Free-Float | 22.71% |
1 day | +3.16% | ||
1 week | +2.02% | ||
1 month | -8.61% | ||
3 months | +9.80% | ||
6 months | -11.15% | ||
Current year | +2.63% |
Managers | Title | Age | Since |
---|---|---|---|
Feng Han
CEO | Chief Executive Officer | 50 | 15-12-31 |
Long Dai
DFI | Director of Finance/CFO | 32 | 23-04-06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Wei Dong Pan
CHM | Chairman | 55 | - |
Huai Yu Wang
BRD | Director/Board Member | 61 | 15-12-31 |
Ji Yong Zhang
CHM | Chairman | - | 15-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 31.32 | +3.16% | 12,605,910 |
24-05-30 | 30.36 | -0.10% | 6,312,940 |
24-05-29 | 30.39 | -.--% | 5,228,708 |
24-05-28 | 30.39 | -1.14% | 5,961,072 |
24-05-27 | 30.74 | +0.13% | 11,492,040 |
End-of-day quote Shenzhen S.E., May 30, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+2.63% | 6.07B | |
+11.85% | 8.05B | |
+5.29% | 7.59B | |
-2.80% | 3.85B | |
-11.22% | 3.55B | |
-7.04% | 1.28B | |
-32.50% | 1.03B | |
+12.52% | 971M | |
-15.69% | 813M | |
+2.88% | 731M |
- Stock Market
- Equities
- 300765 Stock